Europe Fertility Supplements Market Size, Share & Industry Trends Analysis Report By Ingredient, By End-Use (Women and Men), By Distribution Channel, By Product (Capsules, Tablets, Soft Gels, Powder, and Liquid), By Country and Growth Forecast, 2022 - 202

Europe Fertility Supplements Market Size, Share & Industry Trends Analysis Report By Ingredient, By End-Use (Women and Men), By Distribution Channel, By Product (Capsules, Tablets, Soft Gels, Powder, and Liquid), By Country and Growth Forecast, 2022 - 2028

The Europe Fertility Supplements Market would witness market growth of 6.7% CAGR during the forecast period (2022-2028).

A lot of studies have been done on the relationship between micronutrients and fertility to recognize the usage of each type of supplement on a particular being. This is because every person is unique and might react differently to micronutrients affecting fertility. Many advancements and research have boosted customer requirements for fertility supplements. Certain studies found that in a significant percentage of infertile couples, solely the male component was discovered to be infertile.

Poor sperm counts or decreased sperm motility which may be brought on by hormonal abnormalities are the most commonly recognized causes of male infertility. Infertility in women can result from a variety of conditions that affect the ovaries, fallopian tubes, uterus, endocrine system, and many others. People can have either primary or secondary infertility. A person has secondary infertility if at least one previous pregnancy has been accomplished, while primary infertility occurs when a conception has not been achieved.

The prevalence of obesity and the growing number of people with diabetes in Germany are increasing the need for fertility supplements. In obese women, anovulation and menstrual problems are more prevalent. Women who are fat or overweight have an increased chance of miscarrying. These women are more likely to experience sub-fecundity, and infertility, in addition to increased rates of miscarriage, conception, and pregnancy complications; as a result, the nation consumes more of the product.

The Germany market dominated the Europe Fertility Supplements Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $175.1 million by 2028. The UK market is estimated to grow a CAGR of 5.8% during (2022 - 2028). Additionally, The France market would experience a CAGR of 7.5% during (2022 - 2028).

Based on Ingredient, the market is segmented into Synthetic/ Blend of Natural & Synthetic and Natural. Based on End-Use, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Over-the-counter and Prescribed. Based on Product, the market is segmented into Capsules, Tablets, Soft Gels, Powder, and Liquid. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fairhaven Health, Coast Science LLC, LENUS Pharma GesmbH, CellOxess LLC, Orthomol pharmazeutische Vertriebs GmbH, Exeltis USA, Inc. (Grupo INSUD), Yad-Tech, Bionova Lifesciences (Pragati Biocare Pvt. Ltd.), Vitabiotics Ltd., and TTK Healthcare Limited.

Scope of the Study

Market Segments covered in the Report:

By Ingredient

  • Synthetic/ Blend of Natural & Synthetic
  • Natural
By End-use
  • Women
  • Men
By Distribution Channel
  • Over-the-counter
  • Prescribed
By Product
  • Capsules
  • Tablets
  • Soft Gels
  • Powder
  • Liquid
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Fairhaven Health
  • Coast Science LLC
  • LENUS Pharma GesmbH
  • CellOxess LLC
  • Orthomol pharmazeutische Vertriebs GmbH
  • Exeltis USA, Inc. (Grupo INSUD)
  • Yad-Tech
  • Bionova Lifesciences (Pragati Biocare Pvt. Ltd.)
  • Vitabiotics Ltd.
  • TTK Healthcare Limited
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Fertility Supplements Market, by Ingredient
1.4.2 Europe Fertility Supplements Market, by End-use
1.4.3 Europe Fertility Supplements Market, by Distribution Channel
1.4.4 Europe Fertility Supplements Market, by Product
1.4.5 Europe Fertility Supplements Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Fertility Supplements Market by Ingredient
3.1 Europe Synthetic/ Blend of Natural & Synthetic Market by Country
3.2 Europe Natural Market by Country
Chapter 4. Europe Fertility Supplements Market by End-use
4.1 Europe Women Market by Country
4.2 Europe Men Market by Country
Chapter 5. Europe Fertility Supplements Market by Distribution Channel
5.1 Europe Over-the-counter Market by Country
5.2 Europe Prescribed Market by Country
Chapter 6. Europe Fertility Supplements Market by Product
6.1 Europe Capsules Market by Country
6.2 Europe Tablets Market by Country
6.3 Europe Soft Gels Market by Country
6.4 Europe Powder Market by Country
6.5 Europe Liquid Market by Country
Chapter 7. Europe Fertility Supplements Market by Country
7.1 Germany Fertility Supplements Market
7.1.1 Germany Fertility Supplements Market by Ingredient
7.1.2 Germany Fertility Supplements Market by End-use
7.1.3 Germany Fertility Supplements Market by Distribution Channel
7.1.4 Germany Fertility Supplements Market by Product
7.2 UK Fertility Supplements Market
7.2.1 UK Fertility Supplements Market by Ingredient
7.2.2 UK Fertility Supplements Market by End-use
7.2.3 UK Fertility Supplements Market by Distribution Channel
7.2.4 UK Fertility Supplements Market by Product
7.3 France Fertility Supplements Market
7.3.1 France Fertility Supplements Market by Ingredient
7.3.2 France Fertility Supplements Market by End-use
7.3.3 France Fertility Supplements Market by Distribution Channel
7.3.4 France Fertility Supplements Market by Product
7.4 Russia Fertility Supplements Market
7.4.1 Russia Fertility Supplements Market by Ingredient
7.4.2 Russia Fertility Supplements Market by End-use
7.4.3 Russia Fertility Supplements Market by Distribution Channel
7.4.4 Russia Fertility Supplements Market by Product
7.5 Spain Fertility Supplements Market
7.5.1 Spain Fertility Supplements Market by Ingredient
7.5.2 Spain Fertility Supplements Market by End-use
7.5.3 Spain Fertility Supplements Market by Distribution Channel
7.5.4 Spain Fertility Supplements Market by Product
7.6 Italy Fertility Supplements Market
7.6.1 Italy Fertility Supplements Market by Ingredient
7.6.2 Italy Fertility Supplements Market by End-use
7.6.3 Italy Fertility Supplements Market by Distribution Channel
7.6.4 Italy Fertility Supplements Market by Product
7.7 Rest of Europe Fertility Supplements Market
7.7.1 Rest of Europe Fertility Supplements Market by Ingredient
7.7.2 Rest of Europe Fertility Supplements Market by End-use
7.7.3 Rest of Europe Fertility Supplements Market by Distribution Channel
7.7.4 Rest of Europe Fertility Supplements Market by Product
Chapter 8. Company Profiles
8.1 TTK Healthcare Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.2 Exeltis Pharmaceuticals Holding, SL (grupo INSUD)
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.3 Bionova Lifesciences (Pragati Biocare Pvt. Ltd.)
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.4 Vitabiotics Ltd.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.5 Coast Science LLC
8.5.1 Company Overview
8.6 LENUS Pharma GesmbH
8.6.1 Company Overview
8.7 Orthomol pharmazeutische Vertriebs GmbH
8.7.1 Company Overview
8.8 CellOxess LLC
8.8.1 Company Overview
8.9 Yad-Tech
8.9.1 Company Overview
8.10. Fairhaven Health, LLC
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings